Deciphera Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, after Year Five
Deciphera Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $5.54 million as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2024-02-07
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $5.54M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $10.72M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $15.14M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $18.52M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2023-12-31 | $5.54M 10-K · filed 2024-02-07 |
| 2022-12-31 | $10.72M 10-K · filed 2023-02-07 |
| 2021-12-31 | $15.14M 10-K · filed 2022-02-08 |
| 2020-12-31 | $18.52M 10-K · filed 2021-02-09 |
| 2020-09-30 | $18.52M 10-Q · filed 2020-11-05 |
| 2019-12-31 | $11.56M 10-K · filed 2020-03-09 |